<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Life-threatening <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> may complicate the hospital course of patients with ST-segment elevation <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">STEMI</z:e>) undergoing primary percutaneous coronary intervention (PPCI) </plain></SENT>
<SENT sid="1" pm="."><plain>The optimal duration of electrocardiographic monitoring in such patients is not well established </plain></SENT>
<SENT sid="2" pm="."><plain>We aimed to determine the incidence and the time of occurrence of life-threatening <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">STEMI</z:e> patients undergoing PPCI </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Data of 382 consecutive patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">STEMI</z:e> undergoing PPCI were analysed regarding the occurrence of <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>), sustained <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> (sVT) or <z:hpo ids='HP_0001662'>bradycardia</z:hpo> necessitating temporary or permanent pacing </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Of these patients, 55% had inferior <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">STEMI</z:e>, 41% anterior and 4% lateral <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">STEMI</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:mpath ids='MPATH_124'>infarct</z:mpath>-related arteries were the right in 41%, the left anterior descending in 41%, the left circumflex in 16%, the left main stem in 1% and a vein graft in &lt;1% </plain></SENT>
<SENT sid="6" pm="."><plain>During hospitalisation, 27 (7.0%) patients developed 29 life-threatening <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> (incidence 7.6%): 19 episodes occurred during PPCI (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> n = 11, <z:hpo ids='HP_0001662'>bradycardia</z:hpo> n = 8), 9 episodes during the first 24 hours after PPCI (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> n = 7, sVT n = 2), and 1 sVT episode in a hypokalemic patient on the 4th post-procedural day </plain></SENT>
<SENT sid="7" pm="."><plain>A total of 17 patients (4.5%) died within the first 30 days, and 3 of these died during the PPCI procedure </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Life-threatening <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> occur in a considerable proportion of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">STEMI</z:e> patients undergoing PPCI during hospitalisation </plain></SENT>
<SENT sid="9" pm="."><plain>Most of these <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> occur during the PPCI procedure </plain></SENT>
<SENT sid="10" pm="."><plain>Post-procedural life-threatening <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> are virtually limited to the first 24 hours after PPCI </plain></SENT>
<SENT sid="11" pm="."><plain>Thus, routine electrocardiographic monitoring beyond the first 24 hours after PPCI might not be required in most patients with uncomplicated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">STEMI</z:e> </plain></SENT>
</text></document>